Patents Assigned to ViraTox, L.L.C.
  • Patent number: 8741954
    Abstract: A novel composition comprised of a monocarboxylic fatty acid synergistically enhanced with a dual quaternary ammonium compound to provide immediate fungal and sporicidal destruction with long term residual resistance.
    Type: Grant
    Filed: February 21, 2008
    Date of Patent: June 3, 2014
    Assignee: ViraTox, L.L.C.
    Inventor: Charles L. Capps
  • Publication number: 20100144877
    Abstract: A novel composition comprised of a monocarboxylic fatty acid synergistically enhanced with a dual quaternary ammonium compound to provide immediate fungal and sporicidal destruction with long term residual resistance.
    Type: Application
    Filed: February 21, 2008
    Publication date: June 10, 2010
    Applicant: VIRATOX, L.L.C.
    Inventor: Charles L. Capps
  • Publication number: 20090232748
    Abstract: This disclosure relates to inventive methods for inactivating viral pathogens comprising providing a virucidal composition comprising a liquid media containing less than 1% weight per volume of a quaternary ammonium compound, such as cetylpyridinium chloride and between 0% and 0.5% weight per volume of citric acid, and contacting a surface targeted for disinfection with the virucidal composition. This disclosure further relates to inventive virucidal compositions comprising a liquid media, a quaternary ammonium compound, such as cetylpyridinium chloride, at a concentration of less than 1% weight per volume, citric acid at a concentration of between 0.0% and 0.5% weight per volume, an extender, and an enhancer.
    Type: Application
    Filed: March 18, 2009
    Publication date: September 17, 2009
    Applicant: ViraTox, L.L.C.
    Inventor: Charles L. Capps
  • Publication number: 20050100612
    Abstract: This disclosure relates to inventive methods for inactivating viral pathogens in which the steps of the methods include: (a) providing a virucidal composition comprising a liquid media containing less than 1% weight per volume cetylpyridinium chloride; and (b) contacting the virucidal composition with a surface targeted for disinfection. This disclosure further relates to inventive virucidal compositions, in which the compositions include: (a) a liquid media; (b) cetylpyridinium chloride in solution in the liquid media at a concentration of less than 1% weight per volume; (c) an extender; and (d) an enhancer.
    Type: Application
    Filed: September 10, 2004
    Publication date: May 12, 2005
    Applicant: ViraTox, L.L.C.
    Inventor: Charles Capps
  • Publication number: 20050100601
    Abstract: This disclosure relates to inventive methods for inactivating viral pathogens in which the steps of the methods include: (a) providing a virucidal composition comprising a liquid media containing less than 1% weight per volume cetylpyridinium chloride; and (b) contacting the virucidal composition with a surface targeted for disinfection. This disclosure further relates to inventive virucidal compositions, in which the compositions include: (a) a liquid media; (b) cetylpyridinium chloride in solution in the liquid media at a concentration of less than 1% weight per volume; (c) an extender; and (d) an enhancer.
    Type: Application
    Filed: November 7, 2003
    Publication date: May 12, 2005
    Applicant: ViraTox, L.L.C.
    Inventor: Charles Capps